Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Insiders Are Dumping These Three Stocks Despite Strong Performance

Page 1 of 2

While many believe that insider trading usually represents some insignificant noise in the financial markets, extensive research has proven this train of thought to be wrong. Generally, insider buying is relatively straightforward to interpret and is usually perceived as a bullish sign, but one should also take into account the likelihood of insiders’ accuracy when making purchases. Sometimes, equities can make peculiar swings and ignore intrinsic value and future prospects, so insiders may be wrong on some occasions as well. But what can we make of insider selling? As a general rule, insider selling is perceived as a bearish sign, but it is already common knowledge that insiders may sell shares for numerous reasons unrelated to their companies’ future prospects. Even so, some insider sales can provide a general overview of how insiders feel about their companies’ stock and their forthcoming future. Having said that, this article will discuss the insider selling activity registered at three companies in the past few days.

everything possible/

everything possible/

Prior to discussing the insider trading activity, let’s make you familiar with what Insider Monkey does besides providing high-quality articles. At Insider Monkey, we track hedge funds and prominent investors because our research has shown that historically their stock picks delivered superior risk-adjusted returns. This is especially true in the small-cap space. The 50 most popular large-cap stocks among hedge funds had a monthly alpha of about 6 basis points per month between 1999 and 2012; however the 15 most popular small-cap stocks delivered a monthly alpha of 80 basis points during the same period. This means investors would have generated 10 percentage points of alpha per year simply by imitating hedge funds’ top 15 small-cap ideas. We have been tracking the performance of these stocks since the end of August 2012 in real time and these stocks beat the market by 53 percentage points (102% return vs. S&P 500’s 48.7% gain) over the last 37 months (see the details here).

Let’s start off by examining the insider trading activity at information technology channel company Wayside Technology Group Inc. (NASDAQ:WSTG). Chairman and Chief Executive Officer Simon F. Nynens unloaded 9,774 shares on Monday at a sale price of roughly $18.55 per unit. The CEO also discarded 4,546 shares last week at prices in the range of $19 to 19.06 per share, along with an additional 4,757 shares that were withheld for meeting tax obligations. After these transactions, the CEO currently holds a stake of 231,713 shares. At the end of October, Wayside Technology Group Inc. (NASDAQ:WSTG) reported its third-quarter financial results, positing diluted earnings per share (EPS) of $0.33 on net sales of $97.7 million. This compares with diluted EPS of $0.29 on net sales of $90.5 million reported in the same quarter last year. The shares of the IT company are nearly 7% in the green year-to-date, and are currently trading at a trailing P/E ratio of 14.79 (the median for the S&P 500 companies equates 23.41). Jim Simons’ Renaissance Technologies was bullish on Wayside Technology Group Inc. (NASDAQ:WSTG) at the end of the June quarter, owning approximately 211,000 shares.

Follow Wayside Technology Group Inc. (NASDAQ:WSTG)
Trade (NASDAQ:WSTG) Now!

The second page discloses the insider selling activity at NxStage Medical Inc. (NASDAQ:NXTM) and Virtusa Corporation (NASDAQ:VRTU).

Page 1 of 2

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!